MEDICISRX Trademark

Trademark Overview

On Friday, September 24, 2010, a trademark application was filed for MEDICISRX with the United States Patent and Trademark Office. The USPTO has given the MEDICISRX trademark a serial number of 85138151. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, February 8, 2019. This trademark is owned by Medicis Pharmaceutical Corporation. The MEDICISRX trademark is filed in the Advertising, Business and Retail Services category with the following description:

Providing incentive award programs for customers through rebates on selected pharmaceutical products
medicisrx

General Information

Serial Number85138151
Word MarkMEDICISRX
Filing DateFriday, September 24, 2010
Status710 - CANCELLED - SECTION 8
Status DateFriday, February 8, 2019
Registration Number4168588
Registration DateTuesday, July 3, 2012
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, August 30, 2011

Trademark Statements

Description of MarkThe mark consists of the word "MEDICIS" followed by a capital letter "R" then the letter "x" as a subscript with no spaces in between any letter.
Pseudo MarkMEDIC IS RX
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesProviding incentive award programs for customers through rebates on selected pharmaceutical products

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 8, 2019
Primary Code035
First Use Anywhere DateFriday, January 13, 2012
First Use In Commerce DateFriday, January 13, 2012

Trademark Owner History

Party NameMedicis Pharmaceutical Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressScottsdale, AZ 85256
Party NameMedicis Pharmaceutical Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressScottsdale, AZ 85256
Party NameMedicis Pharmaceutical Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressScottsdale, AZ 85256

Trademark Events

Event DateEvent Description
Monday, December 27, 2010ASSIGNED TO EXAMINER
Wednesday, June 22, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 28, 2010NEW APPLICATION ENTERED
Wednesday, September 29, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 30, 2010NOTICE OF PSEUDO MARK MAILED
Tuesday, January 4, 2011NON-FINAL ACTION WRITTEN
Tuesday, January 4, 2011NON-FINAL ACTION E-MAILED
Tuesday, January 4, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 18, 2012USE AMENDMENT FILED
Wednesday, June 22, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 22, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, June 25, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 21, 2011ASSIGNED TO LIE
Friday, July 22, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, August 30, 2011PUBLISHED FOR OPPOSITION
Tuesday, August 30, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 25, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, April 18, 2012TEAS STATEMENT OF USE RECEIVED
Tuesday, May 15, 2012STATEMENT OF USE PROCESSING COMPLETE
Wednesday, May 1, 2013ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, January 21, 2015ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, July 3, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, May 11, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, May 19, 2012ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, May 21, 2012DATA MODIFICATION COMPLETED
Saturday, May 26, 2012LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, May 29, 2012NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 3, 2012REGISTERED-PRINCIPAL REGISTER
Wednesday, April 16, 2025ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Friday, February 8, 2019CANCELLED SEC. 8 (6-YR)

Related Keywords

medicisrx rebates selected pharmaceutical products through customers incentive award programs providing